These press releases are intended for business journalists and analysts/investors
GSK prioritises whooping cough vaccine availability for those most at risk of the disease and confirms uninterrupted supply of Boostrix® and Boostrix® IPV to all Australian State, Territory and Federal Government vaccination programs where Boostrix/Boostrix-IPV is the vaccine of choice.
Read more - Whooping cough vaccines availability update Read more
Read more - Anne Belcher to succeed Geoff McDonald as GSK Australia general manager Read more
GSK publishes Medicines Australia transfer of value report
Read more - GSK publishes transfer of value report Read more
• Leading lifestyle commentator Shelly Horton reveals hay fever struggle
• Over 3 million Australians could be affected by hay fever season
• Up to 8 in 10 people with asthma also affected by hay fever
Read more - New VentureWise program on COPD and asthma Read more
- GSK Australia supplies travel vaccines for Olympic Team
Read more - Bactroban (mupirocin) 2% Ointment supply Read more
- Changes trigger better access to the treatment of enlarged prostate
- GPs set to play a more prominent role in managing moderate to severe BPH.
Resumed supply of Zovirax Ophthalmic Ointment confirmed following a global supply shortage.
Read more - Supply of Zovirax Ophthalmic Ointment (aciclovir 3%) resumes Read more